Osteoarthritis Oa clinical trials

Explore recruiting osteoarthritis oa clinical trials.

Recruiting osteoarthritis oa studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Osteoarthritis Oa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Prospective Real-World Evidence Study Evaluating the Effects of Voltaren use on Mobility and Quality of Life

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

A randomized, two-arm, placebo-controlled, participant and investigator-blinded study investigating the efficacy, safety and tolerability of DFV890 in patients with symptomatic knee osteoarthritis

Germany, Spain, Hungary, Czechia, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Multinational, multicentre, double-blind study to evaluate the efficacy and safety of bovine chondroitin sulfate 800 mg tablets versus marine chondroitin sulfate 800 mg tablets in the treatment of pain and functional impairment due to knee osteoarthritis

Czechia, Hungary, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Repurposed Drug Evaluation for Biological Aging, Pain, and Inflammation Reduction in Osteoarthritis

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

J2A-MC-GZPT A Phase 3 Study to Investigate the Efficacy and Safety of Orfor-glipron Once Daily in Participants Who Have Obesity or Overweight and Osteoar-thritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Pla-cebo-Controlled Trial List of Intervention-Specific Appendices (ISAs): ISA1 (GZT1): A Study to Investigate Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee ISA2 (GZT2): A Study to Investigate Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

J1I-MC-GZBJ: A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1); J1I-MC-GOA1: Indication-Specific Appendix (ISA2) for participants with knee osteoarthritis (OA)

Romania, Poland, Hungary, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Osteoarthritis Oa trials by city

Osteoarthritis Oa in Toronto Osteoarthritis Oa in Vancouver Osteoarthritis Oa in Montreal Osteoarthritis Oa in Calgary Osteoarthritis Oa in Edmonton Osteoarthritis Oa in Ottawa Osteoarthritis Oa in Winnipeg Osteoarthritis Oa in Quebec City Osteoarthritis Oa in Hamilton Osteoarthritis Oa in Kitchener Osteoarthritis Oa in London Osteoarthritis Oa in Halifax Osteoarthritis Oa in New York Osteoarthritis Oa in Los Angeles Osteoarthritis Oa in Chicago Osteoarthritis Oa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease